HyperSynergyX: Synergistic Drug Combination Prediction via Hypergraph Modeling and Knowledge Graph-Enhanced Retrieval-Augmented Generation.
1/5 보강
Drug combination therapy is pivotal for complex diseases, but identifying synergistic three-drug regimens remains challenging due to both combinatorial explosion and the opacity of existing computatio
APA
Wang Q, Wu B, et al. (2026). HyperSynergyX: Synergistic Drug Combination Prediction via Hypergraph Modeling and Knowledge Graph-Enhanced Retrieval-Augmented Generation.. IEEE journal of biomedical and health informatics, PP. https://doi.org/10.1109/JBHI.2026.3673550
MLA
Wang Q, et al.. "HyperSynergyX: Synergistic Drug Combination Prediction via Hypergraph Modeling and Knowledge Graph-Enhanced Retrieval-Augmented Generation.." IEEE journal of biomedical and health informatics, vol. PP, 2026.
PMID
41818020 ↗
Abstract 한글 요약
Drug combination therapy is pivotal for complex diseases, but identifying synergistic three-drug regimens remains challenging due to both combinatorial explosion and the opacity of existing computational models. To address this, we introduce HyperSynergyX, an explainable framework that integrates synergy prediction with mechanistic explanation. Its core predictive component, a Dual-Biased Random Walk on Hypergraphs (DBRWH), models higher-order interactions among drugs on a three drug hypergraph and identifies latent combination patterns via tensor decomposition. To enhance interpretability, we couple DBRWH with a knowledge-graph-enhanced retrieval augmented generation (KG-RAG) module that retrieves mechanistically relevant subgraphs and uses them to generate biologically grounded hypotheses for predicted synergies. On breast-cancer data, DBRWH achieves AUROC/AUPRC of 0.9593/0.9453 under 5-fold cross-validation, and on lung cancer data it achieves 0.9262/0.9481, outperforming strong deep learning and hypergraph baselines. By linking predictive performance with mechanistic interpretability, HyperSynergyX provides a robust and transparent tool to accelerate multi-drug discovery and support rational regimen design in precision oncology. The code is available at: https://github.com/wangqi27/HyperSynergyX.
같은 제1저자의 인용 많은 논문 (5)
- Experience of family caregivers of breast cancer-related lymphedema patients participating in lymphedema management: a phenomenological study.
- [cGAS-STING agonist cGAMP enhances natural killer cell-mediated cytotoxicity against gastric cancer cells].
- Editorial for "Intratumoral Spatial Heterogeneity at Dynamic Contrast-Enhanced MRI for Assessing Tertiary Lymphoid Structures in Hepatocellular Carcinoma".
- Analytical and computational chemistry approaches for mechanistic insights into nanoparticles tumor access.
- Molecular and socioeconomic characteristics of inflammatory breast cancer in the Carolina Breast Cancer Study.